Trial Profile
Safety and pharmacokinetics of CIGB-814 in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Oct 2020
Price :
$35
*
At a glance
- Drugs CIGB 814 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Cuban Center for Genetic Engineering and Biotechnology
- 07 Mar 2017 New trial record